Literature DB >> 6319556

Glycoprotein C of herpes simplex virus type 1: characterization of O-linked oligosaccharides.

S Olofsson, I Sjöblom, M Lundström, S Jeansson, E Lycke.   

Abstract

In contrast to other viral glycoproteins, the herpes simplex virus (HSV) glycoprotein C(gC) binds to the N-acetylgalactosamine-specific Helix pomatia lectin (HPA). In the present paper gC was purified by affinity chromatography with monospecific antibodies and the purified glycoprotein was subjected to protease digestion. HPA-binding protease-resistant glycopeptides were isolated by lectin affinity chromatography. The isolated structures did not bind to concanavalin A and seemed to lack charged groups as determined by ion-exchange chromatography. In gel filtration, the glycopeptides appeared in two peaks with molecular weights higher than 4000. The HPA-binding structures of gC were synthesized in the presence of tunicamycin, indicating that they belong to the O-glycosyl class of oligosaccharides. In addition to HPA-binding oligosaccharides, synthesis of tunicamycin-resistant wheat germ lectin-binding gC oligosaccharides was demonstrable. These were sensitive to sialidase and apparently unrelated to the HPA-binding oligosaccharides.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6319556     DOI: 10.1099/0022-1317-64-12-2735

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  28 in total

1.  Cystein 402 of HIV gp 120 is essential for CD4-binding and resistance of gp 120 to intracellular degradation.

Authors:  A Hemming; A Bolmstedt; P Flodby; L Lundberg; M Gidlund; H Wigzell; S Olofsson
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Lymphocyte and IgG responses to different herpes simplex virus antigens in patients with frequent HSV-1 reactivations.

Authors:  P Ljungman; L Zetterqvist; V A Sundqvist; S Jeansson; A Heimdahl; B Wahren
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

3.  Characterization of the gene encoding herpes simplex virus type 2 glycoprotein C and comparison with the type 1 counterpart.

Authors:  M A Swain; R W Peet; D A Galloway
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

4.  Different populations of herpes simplex virus glycoprotein C discriminated by the carbohydrate-binding characteristics of N-acetylgalactosamine specific lectins (soybean and Helix pomatia). Brief report.

Authors:  S Olofsson; M Lundström; S Jeansson; E Lycke
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

5.  Evidence for post-translational glycosylation of a nonglycosylated precursor protein of herpes simplex virus type 1.

Authors:  T Compton; R J Courtney
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

6.  Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virus.

Authors:  A H Rux; W T Moore; J D Lambris; W R Abrams; C Peng; H M Friedman; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  Latent HSV-1 infection in mice immunized with a zwitterionic detergent-extracted HSV-1 antigen preparation.

Authors:  A al-Ghamdi; R Jennings; H Bentley; C W Potter
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  An O-linked carbohydrate neutralization epitope of HIV-1 gp 120 is expressed by HIV-1 env gene recombinant vaccinia virus.

Authors:  J E Hansen; H Clausen; S L Hu; J O Nielsen; S Olofsson
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

9.  Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.

Authors:  Ieva Bagdonaite; Rickard Nordén; Hiren J Joshi; Sarah L King; Sergey Y Vakhrushev; Sigvard Olofsson; Hans H Wandall
Journal:  J Biol Chem       Date:  2016-04-15       Impact factor: 5.157

10.  Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules.

Authors:  R Tal-Singer; C Peng; M Ponce De Leon; W R Abrams; B W Banfield; F Tufaro; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.